Furfenorex (Frugalan), also known as furfurylmethylamphetamine, is a stimulant drug which was developed in the 1960s and used as an appetite suppressant.[1] It produces methamphetamine as a metabolite,[2] and has been withdrawn from the market due to abuse potential.[3]
![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C15H19NO |
Molar mass | 229.323 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
References
edit- ^ Boissier JR, Dumont C, Ratouis R, Moisy D (May 1967). "[Pharmacologic study of an anorexigenic agent: furfenorex]". Archives Internationales de Pharmacodynamie et de Thérapie. 167 (1): 150–62. PMID 6035092.
- ^ Marsel J, Döring G, Remberg G, Spiteller G (1972). "[Methamphetamine--a metabolite of the anorectics Benzphetamine and Furfenorex]". Zeitschrift für Rechtsmedizin. Journal of Legal Medicine. 70 (4): 245–50. doi:10.1007/BF02079690. PMID 5084766. S2CID 32585009.
- ^ Daspaguta A (March 2009). A Health Educator's Guide to Understanding Drugs of Abuse Testing (1 ed.). Sudbury, Massachusetts: Jones & Bartlett Publishers. ISBN 9780763765897. Retrieved 11 December 2019.